In this case, it's about Covid treatments.
A few days ago, Sen Mastriano posted this on his Facebook page.
In the release, he discloses:
In the near future, I plan to introduce legislation to ensure patients can easily access early treatment drugs following prescription from a licensed provider. The bill will be similar to HB 1741 introduced by Representative Keefer.
I think we know we're headed, amirite?
Here:
For example, a peer-reviewed study published in the International Journal of Antimicrobial Agents found that an early treatment drug combination (hydroxychloroquine and azithromycin) decreased hospitalizations by 84% and resulted in a 5-fold reduction in death.
Yea, he's not telling the entire story. Let me show you.
By way of Blaze, we can find the study here. It was published in December, 2020 and its data was gathered between mid-March and mid-May of that year. Which is to say early on in the pandemic, pre-Delta and pre-Omicron variants.
In the meantime, the FDA declared in June of that year
Today, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation in a clinical trial was not feasible. The agency determined that the legal criteria for issuing an EUA are no longer met. Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA.
And this from Drugs.com:
Multiple studies provide data that hydroxychloroquine (brand name: Plaquenil) does not provide a medical benefit for hospitalized patients with COVID-19. Hydroxychloroquine, an FDA-approved prescription drug used for malaria, rheumatoid arthritis and lupus erythematosus, has been suggested as a possible treatment or preventive for COVID-19 based on demonstrated antiviral or immune system activity.
You should read about those multiple studies. Ah science!
Then there's this from Doug.
Another peer reviewed study conducted by physicians in Brazil between July 2020 and December 2020 examined over 150,000 participants in the city of Itajai and found that those who took Ivermectin (compared to those who did not) had a 56% reduction in hospitalization and a 68% reduction in death.
This has already been debunked. Take a look:
Did a Brazilian city cut hospitalizations and mortality in half after offering everyone ivermectin before COVID-19 vaccinations were available? No, that's not true: City officials in Itajai, Brazil, rebut the draft study, saying less than 10% of the 130,000+ people who started the Itajai health department's regimen of the antiparasitic medication continued taking the doses until the end. The much smaller participation numbers cast doubt on the conclusions of the study, which hasn't been peer-reviewed yet.
Huh. This was posted only last December. I wonder why Pennsylvania State Senator Doug Mastriano didn't choose to inform his constituents about it.
He's using outdated and/or debunked information to support his legislation. In doing so, he's pushing people away from the vaccines.
Senator, you're lying to your constituents and this will inevitably lead (if it hasn't already) to more of them getting getting sick and more of them dying.
Good for you, Pennsylvania State Senator Doug Mastriano. Good for you.
